Richard M. Wright

Richard M. Wright discloses dealings in Celldex Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 August 2022 to 13 November 2025, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 17 November 2025: an option exercise of €53k, in Celldex Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.